BN Business News
Add your company to Business Communicator →

Regulacje i polityka gospodarcza · 26/11/1996

US Department of the Army to Grant Exclusive License to SciClone Pharmaceuticals for Hepatitis C Treatment

The US Department of the Army is set to grant an exclusive license to SciClone Pharmaceuticals, a California-based pharmaceutical company, for its patent applications related to a hepatitis C treatment, following a 60-day objection period.

Source: Federal Register — All DocumentsOpen original release →